Interactions of Ca2+ antagonists at 5-HT2 and H2 receptors and GABA uptake sites
- 30 June 1987
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 8 (6), 200-201
- https://doi.org/10.1016/0165-6147(87)90057-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Verapamil as an apparent competitive antagonist of the serotonin receptor of rabbit isolated aortaGeneral Pharmacology: The Vascular System, 1986
- Characteristics of the Inhibition of Ligand Binding to Serotonin Receptors in Rat Brain Membranes by VerapamilThe Japanese Journal of Pharmacology, 1986
- Interactions of verapamil, D 600, flunarizine and nifedipine with cerebral histamine-receptorsNeurochemistry International, 1986
- Verapamil, an antagonist at 5-Hydroxytryptamine receptors of human blood plateletsEuropean Journal of Pharmacology, 1985
- Competitive inhibition of 5-HT receptors in rabbit isolated aorta by the Ca2+-antagonist methoxyverapamil (D 600)Neurochemistry International, 1984
- Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600European Journal of Pharmacology, 1984
- Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cationsEuropean Journal of Pharmacology, 1984
- Some calcium and lysosome antagonists inhibit 3H-spirerone binding to the porcine anterior pituitaryLife Sciences, 1982
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977
- Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitorsPflügers Archiv - European Journal of Physiology, 1972